Introduction to and Organization of the Laboratory
Hanmi Fine Chemical is striving to develop into a global Active Pharmaceutical Ingredient corporation with an unending passion for R&D.
- Unending passion for R&D
- Hanmi Fine Chemical is leading the development of Active Pharmaceutical Ingredients with the highest level of R&D investment among all other companies in the same industry (higher than 7% of sales). Since the development of Cefotaxime, a Cephalosporin antibiotic, for the first time in Korea in 1984, we have exported our technologies including Ceftriaxone (1987) and Gemcitabine (2005) to leading global pharmaceutical companies. We will continue to grow into a leading, globally-active pharmaceutical ingredient development company that contributes to the promotion of human health and a healthy society through continuous creation, innovation, and active investment in small molecules, peptides, and oligonucleotide pharmaceuticals.